| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00017 | 1 |